(Q38294104)

1 September 2017

1 reference

title

Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer (English)

1 reference

Richard van Hillegersberg

1 September 2017

1 reference

1 reference

5

object named as

R van Hillegersberg

1 reference

1 September 2017

S J E Rombouts

1

1 reference

1 September 2017

J A Vogel

2

1 reference

1 September 2017

H C van Santvoort

3

1 reference

1 September 2017

K P van Lienden

4

1 reference

1 September 2017

O R C Busch

6

1 reference

1 September 2017

M G H Besselink

7

1 reference

1 September 2017

I Q Molenaar

8

1 reference

1 September 2017

language of work or name

English

0 references

publication date

18 December 2014

1 reference

British Journal of Surgery

1 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

1 September 2017

volume

102

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

182-193

1 reference

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group

1 September 2017

cites work

1 reference

Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate

21 January 2018

1 reference

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

21 January 2018

1 reference

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience

21 January 2018

1 reference

A Quantitative Analysis of the Voltage-Current Relationships of Fixed Charge Membranes and the Associated Property of “Punch-Through”

21 January 2018

1 reference

High-intensity focused ultrasound: current potential and oncologic applications

21 January 2018

1 reference

Microwave ablation: principles and applications.

21 January 2018

1 reference

The process of freezing and the mechanism of damage during hepatic cryosurgery.

21 January 2018

1 reference

Theory of electrical creation of aqueous pathways across skin transport barriers.

21 January 2018

1 reference

Membrane electroporation: a molecular dynamics simulation

21 January 2018

1 reference

Molecular dynamics simulations of lipid membrane electroporation.

21 January 2018

1 reference

Stereotactic body radiation therapy for nonresectable tumors of the pancreas

21 January 2018

1 reference

Radiation therapy in pancreatic cancer: current practice and future trends.

21 January 2018

1 reference

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas

21 January 2018

1 reference

High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer

21 January 2018

1 reference

Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival

21 January 2018

1 reference

Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated

21 January 2018

1 reference

Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma

21 January 2018

1 reference

Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration.

21 January 2018

1 reference

Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety

21 January 2018

1 reference

Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy

21 January 2018

1 reference

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

Stereotactic body radiation therapy boost in locally advanced pancreatic cancer

21 January 2018

1 reference

Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer

21 January 2018

1 reference

Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer

21 January 2018

1 reference

Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated

21 January 2018

1 reference

Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer

21 January 2018

1 reference

18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

21 January 2018

1 reference

Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series.

21 January 2018

1 reference

Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer

21 January 2018

1 reference

Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

Magnetic resonance-guided high-intensity focused ultrasound treatment of locally advanced pancreatic adenocarcinoma: preliminary experience for pain palliation and local tumor control

21 January 2018

1 reference

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

21 January 2018

1 reference

The investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinoma

21 January 2018

1 reference

Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma

21 January 2018

1 reference

A pilot study on combination of cryosurgery and (125)iodine seed implantation for treatment of locally advanced pancreatic cancer

21 January 2018

1 reference

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

21 January 2018

1 reference

Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of the Pancreas in a Porcine Model

21 January 2018

1 reference

Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

21 January 2018

1 reference

Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma

21 January 2018

1 reference

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

21 January 2018

1 reference

Irreversible electroporation of the pancreas: definitive local therapy without systemic effects

21 January 2018

1 reference

Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models

21 January 2018

1 reference

Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.

21 January 2018

1 reference

Irreversible electroporation ablation: is all the damage nonthermal?

21 January 2018

1 reference

Microwave Ablation of Pancreatic Head Cancer: Safety and Efficacy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.9716

1 reference

1 September 2017

1 reference